Sistema de Salut de Catalunya
Institut Català de la Salut
[Marzo C] Hematology and Hemotherapy Department, Hospital Universitari Arnau de Vilanova, Lleida, Catalunya, Spain. [Solanich T] Vascular Surgery Department, Hospital Universitari Parc Taulí, Sabadell, Spain. [Tassies D] Hemotherapy and Hemostasis Department, Hospital Clinic Barcelona, Barcelona, Catalunya, Spain. [Pina E] Thrombosis and Haemostasis Department, Hospital Universitari Bellvitge, Hospitalet de Llobregat, Barcelona, Spain. [Antonio Rebollo M] Oncogeriatrics Unit, Institut Català d’Oncologia, Barcelona, Spain. [Gallardo E] Servei d’Oncologia Mèdica, Parc Taulí Hospital Universitari, Sabadell, Barcelona, Spain. Institut d’Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Barcelona, Spain. [Serradell S] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain
Vall d'Hebron Barcelona Hospital Campus
2025-11-03T09:32:57Z
2025-11-03T09:32:57Z
2025-10
Consensus; Venous thromboembolism
Consenso; Tromboembolia venosa
Consens; Tromboembolisme venós
Venous thromboembolism (VTE) can present different challenging situations for which high-quality evidence to guide optimal preventive and therapeutic management is lacking and for which clinical practice guidelines have not established solid recommendations. The aim of this article is to achieve consensus on a proposal of action for the clinical management of complex, clinically relevant situations with a low level of evidence which generate great uncertainty—the duration of VTE treatment and the role of thrombus recanalization, the prevention of VTE within the context of pregnancy, management of anticoagulant treatment in patients with VTE and special characteristics, such as renal insufficiency and obesity, the therapeutic management of pluripathological and polymedicated older patients with VTE, and finally, primary ambulatory thromboembolic prevention in cancer patients. This consensus article arose from a collaboration of experts in VTE from different medical specialties.
Article
Versió publicada
Anglès
Anticoagulants (Medicina); Obesitat; Ronyons - Malalties; Decisió, Presa de; Tromboembolisme; CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Hematologic Agents::Anticoagulants; PSYCHIATRY AND PSYCHOLOGY::Behavior and Behavior Mechanisms::Psychology, Social::Group Processes::Consensus; DISEASES::Cardiovascular Diseases::Vascular Diseases::Embolism and Thrombosis::Thromboembolism::Venous Thromboembolism; DISEASES::Male Urogenital Diseases::Urologic Diseases::Kidney Diseases::Renal Insufficiency; PHENOMENA AND PROCESSES::Physiological Phenomena::Body Constitution::Body Weights and Measures::Body Size::Body Weight::Overweight::Obesity; COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::fármacos hematológicos::anticoagulantes; PSIQUIATRÍA Y PSICOLOGÍA::conducta y mecanismos de la conducta::psicología social::procesos de grupo::consenso; ENFERMEDADES::enfermedades cardiovasculares::enfermedades vasculares::embolia y trombosis::tromboembolia::tromboembolia venosa; ENFERMEDADES::enfermedades urogenitales masculinas::enfermedades urológicas::enfermedades renales::insuficiencia renal; FENÓMENOS Y PROCESOS::fenómenos fisiológicos::constitución corporal::pesos y medidas corporales::tamaño corporal::peso corporal::sobrepeso::obesidad
Georg Thieme Verlag
Thrombosis and Haemostasis;125(10)
https://doi.org/10.1055/a-2595-1811
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - HVH [3396]
